Research Digest
The Pancreatic Cancer Research Digest is intended to highlight key biomedical news and publications. Below, you can navigate through different topics or download a PDF of the current or archived editions.
Grantee’s Study Suggests Bacteria Can Influence Tumor Growth and Immune Response
A new study published in Cancer Discovery suggests that bacteria present within the pancreatic tumor stroma – and in the gut – have an important impact on cancer progression and immune response. Read More
-
The 30-Year Quest To Tame The 'Wily' Cancer Gene
As highlighted on NPR, RAS has historically been deemed “undruggable” – decades of effort have not resulted in a therapeutic strategy to stop or slow its cancer-causing activity. But researchers have not given up trying to conquer this extremely challenging foe. Read More
-
National Doctors’ Day: Honoring Roles and Importance of Specialists
In honor of National Doctors’ Day, we highlighted disciplines of medical professionals who diagnose and treat pancreatic cancer patients, through the voices of our Scientific and Medical Advisory Board members. Read More
-
Can a Blood Test Lead to Early Detection?
In a recent Science paper, the authors describe a blood test that can detect eight common cancer types through assessment of the levels of circulating proteins and mutations in cell-free DNA. Read More
-
Lutathera® Drug Approved for Pancreatic Neuroendocrine Tumors
The U.S. Food and Drug Administration approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastrointestinal tract called gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Read More
Sign Up for Research Funding Alerts
Donate Now
To continue to fund innovative research, advocate for increased federal resources, provide cutting-edge services to patients and raise awareness nationwide, we need your support. Help us Wage Hope and double pancreatic cancer survival by 2020 by donating today.
Donate Now